Chemoinformaics analysis of L-Aminobutyric-Acid
| Molecular Weight | 234.296 | nRot | 6 |
| Heavy Atom Molecular Weight | 212.12 | nRig | 1 |
| Exact Molecular Weight | 234.158 | nRing | 0 |
| Solubility: LogS | -1.328 | nHRing | 0 |
| Solubility: LogP | -1.652 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 36.7774 |
| nHD | 2 | BPOL | 23.2626 |
| QED | 0.587 |
| Synth | 2.271 |
| Natural Product Likeliness | 1.174 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.025 |
| HIA | 0.059 |
| CACO-2 | -5.357 |
| MDCK | 0.00293047 |
| BBB | 0.702 |
| PPB | 0.186026 |
| VDSS | 0.509 |
| FU | 0.81678 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.074 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.105 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.39 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.274 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.045 |
| CL | 8.958 |
| T12 | 0.632 |
| hERG | 0.025 |
| Ames | 0.02 |
| ROA | 0.448 |
| SkinSen | 0.305 |
| Carcinogencity | 0.102 |
| EI | 0.191 |
| Respiratory | 0.532 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.661932 |